{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:02:06Z","timestamp":1791597726582,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NHS Endowment","award":["09\/03"],"award-info":[{"award-number":["09\/03"]}]},{"DOI":"10.13039\/501100004074","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT080782MF"],"award-info":[{"award-number":["WT080782MF"]}],"id":[{"id":"10.13039\/501100004074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.expneurol.2015.07.024","type":"journal-article","created":{"date-parts":[[2015,8,5]],"date-time":"2015-08-05T14:55:17Z","timestamp":1438786517000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"273","author":[{"given":"Ross B.","family":"Mounsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger G.","family":"Pertwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Teismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2015.07.024_bb0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0010","article-title":"Neuroprotective effect of JZL184 in MPP-treated SH-SY5Y cells through CB receptors","author":"Aymerich","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.05-4743fje","article-title":"Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice","volume":"20","author":"Bilsland","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/bbrc.1999.0254","article-title":"Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function","volume":"256","author":"Bisogno","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0025","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0035","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2015.11","article-title":"The CB cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","author":"Blazquez","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2011.01.024","article-title":"Endocannabinoid 2-arachidonoylglycerol protects neurons against beta-amyloid insults","volume":"178","author":"Chen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0050","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bjp.0707425","article-title":"The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation","volume":"152","author":"Comelli","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0070","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0075","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0085","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.2011.01444.x","article-title":"Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-gamma","volume":"163","author":"Du","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0090","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fernandez-Suarez","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0095","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.biocel.2005.02.010","article-title":"Effects of repeated administration with CP-55,940, a cannabinoid CB1 receptor agonist on the metabolism of the hepatic heme","volume":"37","author":"Fontanellas","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9)-THCV in animal models of Parkinson's disease","volume":"163","author":"Garcia","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0110","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0305","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00109-007-0233-y","article-title":"Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro","volume":"85","author":"Iuvone","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0125","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbr.2009.04.035","article-title":"The CB(1) antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease","volume":"203","author":"Kelsey","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0130","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.chembiol.2007.10.017","article-title":"URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices","volume":"14","author":"King","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0135","doi-asserted-by":"crossref","first-page":"33744","DOI":"10.1074\/jbc.M007088200","article-title":"Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2","volume":"275","author":"Kozak","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/glia.20756","article-title":"2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells","volume":"57","author":"Kreutz","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.2003.01595.x","article-title":"Compounds acting at the endocannabinoid and\/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease","volume":"84","author":"Lastres-Becker","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0155","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson's disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0165","doi-asserted-by":"crossref","first-page":"20270","DOI":"10.1073\/pnas.0909411106","article-title":"Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo","volume":"106","author":"Long","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0160","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1021\/jm9016976","article-title":"Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases","volume":"53","author":"Long","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0175","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1208\/aapsj080234","article-title":"Cannabinoid receptors and endocannabinoids: evidence for new players","volume":"8","author":"Mackie","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0180","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2006.04.010","article-title":"Protective activation of the endocannabinoid system during ischemia in dopamine neurons","volume":"24","author":"Melis","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.2010.00769.x","article-title":"CB1 cannabinoid receptors promote oxidative\/nitrosative stress, inflammation and cell death in a murine nephropathy model","volume":"160","author":"Mukhopadhyay","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0404.1998.tb01736.x","article-title":"Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease","volume":"98","author":"Muller","year":"1998","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0210","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0215","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1124\/jpet.109.158162","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling","volume":"331","author":"Pan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0230","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","author":"Panikashvili","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.jcbfm.9600047","article-title":"CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition","volume":"25","author":"Panikashvili","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0235","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0240","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bjp.0701076","article-title":"Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor","volume":"121","author":"Riendeau","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12035-007-0004-3","article-title":"Cannabinoids and neuroprotection in basal ganglia disorders","volume":"36","author":"Sagredo","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0255","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/aws250","article-title":"S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway","volume":"135","author":"Sathe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0260","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0265","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ana.20133","article-title":"l-3-Hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's disease","volume":"56","author":"Tieu","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0275","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1038\/cddis.2013.387","article-title":"The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG","volume":"4","author":"Valdeolivas","year":"2013","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0280","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00018-006-6037-3","article-title":"Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels","volume":"63","author":"van der Stelt","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0285","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.bjp.0706971","article-title":"Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro","volume":"150","author":"Vandevoorde","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","article-title":"New stereological methods for counting neurons","volume":"14","author":"West","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2015.07.024_bb0295","doi-asserted-by":"crossref","first-page":"22601","DOI":"10.1074\/jbc.M800524200","article-title":"Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2015.07.024_bb0300","doi-asserted-by":"crossref","first-page":"14919","DOI":"10.1523\/JNEUROSCI.1165-14.2014","article-title":"Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615300583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488615300583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T08:52:29Z","timestamp":1537433549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488615300583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":60,"alternative-id":["S0014488615300583"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.07.024","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2015.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}